• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tie1 调节血管生成素-2 对人淋巴管内皮细胞的 Tie2 激动作用。

Tie1 regulates the Tie2 agonistic role of angiopoietin-2 in human lymphatic endothelial cells.

机构信息

College of Pharmacy, Ajou University, San 5, Woncheon-Dong, Yeongtong-Gu, Suwon 443-749, Republic of Korea.

出版信息

Biochem Biophys Res Commun. 2012 Mar 9;419(2):281-6. doi: 10.1016/j.bbrc.2012.02.009. Epub 2012 Feb 10.

DOI:10.1016/j.bbrc.2012.02.009
PMID:22342979
Abstract

Although Angiopoietin (Ang) 2 has been shown to function as a Tie2 antagonist in vascular endothelial cells, several recent studies on Ang2-deficient mice have reported that, like Ang1, Ang2 acts as a Tie2 agonist during in vivo lymphangiogenesis. However, the mechanism governing the Tie2 agonistic activity of Ang2 in lymphatic endothelial cells has not been investigated. We found that both Ang1 and Ang2 enhanced the in vitro angiogenic and anti-apoptotic activities of human lymphatic endothelial cells (HLECs) through the Tie2/Akt signaling pathway, while only Ang1 elicited such effects in human umbilical vein vascular endothelial cells (HUVECs). This Tie2-agonistic effect of Ang2 in HLECs resulted from low levels of physical association between Tie2 and Tie1 receptors due to a reduced level of Tie1 expression in HLECs compared to HUVECs. Overexpression of Tie1 and the resulting increase in formation of Tie1/Tie2 heterocomplexes in HLECs completely abolished Ang2-mediated Tie2 activation and the subsequent cellular responses, but did not alter the Ang1 function. This inhibitory role of Tie1 in Ang2-induced Tie2 activation was also confirmed in non-endothelial cells with adenovirus-mediated ectopic expression of Tie1 and/or Tie2. To our knowledge, this study is the first to describe how Ang2 acts as a Tie2 agonist in HLECs. Our results suggest that the expression level of Tie1 and its physical interaction with Tie2 defines whether Ang2 functions as a Tie2 agonist or antagonist, thereby determining the context-dependent differential endothelial sensitivity to Ang2.

摘要

虽然血管生成素(Ang)2 已被证明在血管内皮细胞中作为 Tie2 的拮抗剂发挥作用,但最近几项关于 Ang2 缺陷小鼠的研究报告称,与 Ang1 一样,Ang2 在体内淋巴管生成过程中作为 Tie2 的激动剂发挥作用。然而,Ang2 在淋巴管内皮细胞中作为 Tie2 激动剂的作用机制尚未得到研究。我们发现,Ang1 和 Ang2 均可通过 Tie2/Akt 信号通路增强人淋巴管内皮细胞(HLEC)的体外血管生成和抗凋亡活性,而 Ang1 仅在人脐静脉血管内皮细胞(HUVEC)中产生这种作用。与 HUVEC 相比,HLEC 中 Tie1 表达水平降低,导致 Tie2 和 Tie1 受体之间的物理结合水平降低,从而导致 Ang2 在 HLEC 中产生 Tie2 激动作用。HLEC 中 Tie1 的过表达及其导致的 Tie1/Tie2 异源二聚体形成增加,完全消除了 Ang2 介导的 Tie2 激活和随后的细胞反应,但不改变 Ang1 的功能。在非内皮细胞中,通过腺病毒介导的 Tie1 和/或 Tie2 异位表达,也证实了 Tie1 在 Ang2 诱导的 Tie2 激活中的抑制作用。据我们所知,这项研究首次描述了 Ang2 如何在 HLEC 中作为 Tie2 激动剂发挥作用。我们的结果表明,Tie1 的表达水平及其与 Tie2 的物理相互作用决定了 Ang2 是作为 Tie2 激动剂还是拮抗剂发挥作用,从而决定了 Ang2 对内皮细胞的上下文依赖性差异敏感性。

相似文献

1
Tie1 regulates the Tie2 agonistic role of angiopoietin-2 in human lymphatic endothelial cells.Tie1 调节血管生成素-2 对人淋巴管内皮细胞的 Tie2 激动作用。
Biochem Biophys Res Commun. 2012 Mar 9;419(2):281-6. doi: 10.1016/j.bbrc.2012.02.009. Epub 2012 Feb 10.
2
Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells.Tie受体之间的相互作用调节血管生成素2在内皮祖细胞中的血管生成活性。
Cardiovasc Res. 2006 Dec 1;72(3):394-402. doi: 10.1016/j.cardiores.2006.08.002. Epub 2006 Aug 7.
3
Tie1 controls angiopoietin function in vascular remodeling and inflammation.Tie1在血管重塑和炎症中控制血管生成素的功能。
J Clin Invest. 2016 Sep 1;126(9):3495-510. doi: 10.1172/JCI84923. Epub 2016 Aug 22.
4
Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface.血管生成素-1 和 -2 对内皮细胞表面受体酪氨酸激酶 Tie2 的作用是不同调节的。
Cell Signal. 2010 Mar;22(3):527-32. doi: 10.1016/j.cellsig.2009.11.007.
5
Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival.孤儿内皮受体Tie1的激活可改变Tie2介导的细胞内信号传导和细胞存活。
FASEB J. 2007 Oct;21(12):3171-83. doi: 10.1096/fj.07-8487com. Epub 2007 May 15.
6
Roles of the receptor tyrosine kinases Tie1 and Tie2 in mediating the effects of angiopoietin-1 on endothelial permeability and apoptosis.受体酪氨酸激酶Tie1和Tie2在介导血管生成素-1对内皮细胞通透性和凋亡作用中的角色。
Microvasc Res. 2009 Mar;77(2):187-91. doi: 10.1016/j.mvr.2008.09.003. Epub 2008 Sep 20.
7
Hypoxia reduces endothelial Ang1-induced Tie2 activity in a Tie1-dependent manner.缺氧以依赖 Tie1 的方式减少内皮细胞 Ang1 诱导的 Tie2 活性。
Biochem Biophys Res Commun. 2013 Jul 12;436(4):691-7. doi: 10.1016/j.bbrc.2013.06.018. Epub 2013 Jun 14.
8
Expression and function of Angiopoietins and their tie receptors in human basophils and mast cells.人嗜碱性粒细胞和肥大细胞中血管生成素及其受体的表达和功能。
J Biol Regul Homeost Agents. 2013 Jul-Sep;27(3):827-39.
9
Tie1: an orphan receptor provides context for angiopoietin-2/Tie2 signaling.Tie1:一种孤儿受体为血管生成素-2/Tie2信号传导提供背景信息。
J Clin Invest. 2016 Sep 1;126(9):3188-91. doi: 10.1172/JCI89963. Epub 2016 Aug 22.
10
Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology.血管生成素-2 在血管生理学和病理生理学中的作用。
Cells. 2019 May 17;8(5):471. doi: 10.3390/cells8050471.

引用本文的文献

1
Biomarkers for primary graft dysfunction after lung transplantation: a review of current evidence and future prospects.肺移植术后原发性移植肺功能障碍的生物标志物:当前证据与未来展望综述
Front Physiol. 2025 May 22;16:1557182. doi: 10.3389/fphys.2025.1557182. eCollection 2025.
2
Transcriptomic and Functional Evidence for Differential Effects of MCF-7 Breast Cancer Cell-Secretome on Vascular and Lymphatic Endothelial Cell Growth.转录组学和功能证据表明 MCF-7 乳腺癌细胞分泌组对血管和淋巴管内皮细胞生长的影响存在差异。
Int J Mol Sci. 2022 Jun 28;23(13):7192. doi: 10.3390/ijms23137192.
3
Angiopoietin-2-induced lymphatic endothelial cell migration drives lymphangiogenesis via the β1 integrin-RhoA-formin axis.
血管生成素-2 诱导的淋巴管内皮细胞迁移通过β1 整合素- RhoA-成帽蛋白轴驱动淋巴管生成。
Angiogenesis. 2022 Aug;25(3):373-396. doi: 10.1007/s10456-022-09831-y. Epub 2022 Feb 1.
4
Corneal Lymphangiogenesis: Current Pathophysiological Understandings and Its Functional Role in Ocular Surface Disease.角膜淋巴管生成:当前的病理生理学理解及其在眼表面疾病中的功能作用。
Int J Mol Sci. 2021 Oct 27;22(21):11628. doi: 10.3390/ijms222111628.
5
Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders.靶向血管生成素/血管生成素受体途径:治疗视网膜和呼吸系统疾病的前景。
Drugs. 2021 Oct;81(15):1731-1749. doi: 10.1007/s40265-021-01605-y. Epub 2021 Sep 29.
6
A systems biology model of junctional localization and downstream signaling of the Ang-Tie signaling pathway.血管生成素-血管生成素受体信号通路的连接定位和下游信号的系统生物学模型。
NPJ Syst Biol Appl. 2021 Aug 20;7(1):34. doi: 10.1038/s41540-021-00194-6.
7
Engineering the Lymphatic Network: A Solution to Lymphedema.工程化淋巴管网:治疗淋巴水肿的新途径。
Adv Healthc Mater. 2021 Mar;10(6):e2001537. doi: 10.1002/adhm.202001537. Epub 2021 Jan 27.
8
Decreased lymphatic HIF-2α accentuates lymphatic remodeling in lymphedema.淋巴低氧诱导因子 2α 减少加重淋巴水肿中的淋巴管重塑。
J Clin Invest. 2020 Oct 1;130(10):5562-5575. doi: 10.1172/JCI136164.
9
Lymphatic Endothelial Cell Junctions: Molecular Regulation in Physiology and Diseases.淋巴管内皮细胞连接:生理与疾病中的分子调控
Front Physiol. 2020 May 29;11:509. doi: 10.3389/fphys.2020.00509. eCollection 2020.
10
Angiopoietin-Tie Signaling Pathway in Endothelial Cells: A Computational Model.内皮细胞中的血管生成素-酪氨酸激酶受体信号通路:一种计算模型。
iScience. 2019 Oct 25;20:497-511. doi: 10.1016/j.isci.2019.10.006. Epub 2019 Oct 3.